# Mechanism of SGLT2 Inhibition in the Kidney

> **NCT06291155** · PHASE4 · RECRUITING · sponsor: **University of Michigan** · enrollment: 20 (estimated)

## Conditions studied

- Type 2 Diabetes
- Diabetic Kidney Disease

## Interventions

- **DRUG:** SGLT2 inhibitor

## Key facts

- **NCT ID:** NCT06291155
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-10-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06291155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06291155, "Mechanism of SGLT2 Inhibition in the Kidney". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06291155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*